Literature DB >> 10194178

Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.

E Baraldi1, C Dario, R Ongaro, M Scollo, N M Azzolin, N Panza, N Paganini, F Zacchello.   

Abstract

While it is known that exhaled nitric oxide (ENO) is increased in adults and school children with asthma exacerbation probably as an expression of disease activity, no studies have investigated whether this phenomenon also occurs in infants and young children with recurrent wheeze exacerbation. We measured ENO in 13 young children (mean age 20.2 mo) with recurrent wheeze (Group 1) during an acute episode and after 5 d of oral prednisone therapy. ENO was measured also in nine healthy control subjects (Group 2) (mean age 16.9 mo) and in six children with a first-time viral wheezy episode (Group 3) (mean age 11 mo). To measure ENO, infants inhaled NO-free air via a face mask from a reservoir and, through a nonrebreathing valve, exhaled in a collecting bag that was analyzed by chemiluminescence. To address the question of whether the levels of ENO collected in the bag are a reflection of the pulmonary airway, ENO determinations were performed in two healthy infants before and after tracheal intubation for elective surgery. During the acute episode of wheezing the mean (+/- SEM) value of ENO in children with recurrent wheeze (Group 1) was 14.1 +/- 1.8 ppb, almost threefold higher than in healthy control subjects (5.6 +/- 0.5 ppb, p < 0.001). After steroid therapy we found a mean fall of 52% in ENO (5.9 +/- 0.7 ppb, p < 0.01) compared with baseline values. ENO values measured before and after intubation in two infants were 6 ppb and 5 ppb in one child and 7 ppb and 6 ppb in the other one. The mean value of ENO of children with first-time wheeze (Group 3) was 8.3 +/- 1.3 ppb, significantly lower (p < 0.05) than the value of children with recurrent wheeze (Group 1). In conclusion, we describe a method to measure ENO in young children and show that infants with recurrent wheeze have elevated levels of ENO during exacerbation that rapidly decrease after steroid therapy. This suggests that, in these children, airway inflammation could be present at a very early stage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194178     DOI: 10.1164/ajrccm.159.4.9807084

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

Review 1.  The role of inflammation in childhood asthma.

Authors:  F Chedevergne; M Le Bourgeois; J de Blic; P Scheinmann
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

2.  Tidal off-line exhaled nitric oxide measurements in a pre-school population.

Authors:  Isabelle Meyts; Marijke Proesmans; Veerle Van Gerven; Karel Hoppenbrouwers; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2003-05-09       Impact factor: 3.183

Review 3.  Exhaled nitric oxide measurements: clinical application and interpretation.

Authors:  D R Taylor; M W Pijnenburg; A D Smith; J C De Jongste
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

4.  Controlled low flow off line sampling of exhaled nitric oxide in children.

Authors:  Q Jöbsis; H C Raatgeep; W C Hop; J C de Jongste
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

5.  Exhaled Nitric Oxide in Acute Phase of Bronchiolitis and Its Relation with Episodes of Subsequent Wheezing in Children of Preschool Age.

Authors:  Jose Antonio Peña Zarza; Borja Osona; Jose Antonio Gil-Sanchez; Joan Figuerola
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2012-06       Impact factor: 1.349

6.  Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma.

Authors:  L P Malmberg; A S Pelkonen; T Haahtela; M Turpeinen
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

7.  Effect of elevated exhaled nitric oxide levels on the risk of respiratory tract illness in preschool-aged children with moderate-to-severe intermittent wheezing.

Authors:  Avraham Beigelman; David T Mauger; Brenda R Phillips; Robert S Zeiger; Lynn M Taussig; Robert C Strunk; Leonard B Bacharier
Journal:  Ann Allergy Asthma Immunol       Date:  2009-08       Impact factor: 6.347

8.  Exhaled nitric oxide predicts persistence of wheezing, exacerbations, and decline in lung function in wheezy infants and toddlers.

Authors:  M Elliott; S L Heltshe; D C Stamey; E S Cochrane; G J Redding; J S Debley
Journal:  Clin Exp Allergy       Date:  2013-12       Impact factor: 5.018

9.  Assessment of airway inflammation with exhaled NO measurement.

Authors:  E Hatziagorou; J Tsanakas
Journal:  Hippokratia       Date:  2007-04       Impact factor: 0.471

10.  Exhaled nitric oxide measurements in the first 2 years of life: methodological issues, clinical and epidemiological applications.

Authors:  Carmelo Gabriele; Fernando M de Benedictis; Johan C de Jongste
Journal:  Ital J Pediatr       Date:  2009-07-20       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.